A Phase I, Open-Label, Randomized, Crossover Trial in 16 Healthy Subjects to Investigate the Potential Pharmacokinetic Interaction Between Telaprevir and Escitalopram at Steady-State.
Phase of Trial: Phase I
Latest Information Update: 11 Dec 2009
At a glance
- Drugs Escitalopram; Telaprevir
- Indications Anxiety disorders; Depressive disorders; Hepatitis C
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 11 Dec 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Nov 2009 Planned end date changed from 1 Dec 2009 to 1 Nov 2009 as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov.